La OMS suspende su ensayo de hidroxicloroquina en pacientes de COVID-19 debido a problemas de seguridad

By
IBL News
-


The World Health Organization said that it has suspended its trial of the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns.

Fuente: Youtube